Danoprevir: Interim Phase II data

Interim data from 38 treatment-naive, non-cirrhotic patients with HCV genotype 1 infection in the Taiwanese Phase II EVEREST trial

Read the full 192 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE